EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons

Yu-En Lin iD, Ebsy Jaimon iD, Francesca Tonelli iD, Suzanne R Pfeffer iD

Life Science Alliance · 2025-01 · 8 (1) · e202402922

DOI: 10.26508/lsa.202402922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 13.11.2024. Verfasst von Yu-En Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Interneurons, Cilia, Parvalbumins, Leucine-Rich Repeat Serine-Threonine Protein Kinase-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Aligning Science Across Parkinson’s.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease–associated, activating mutations in the LRRK2 kinase block primary cilium formation in cell culture and in specific cell types in the brain. In the striatum that is important for movement control, about half of astrocytes and cholinergic interneurons, but not the predominant medium spiny neurons, lose their primary cilia. Here, we show that mouse and human striatal parvalbumin interneurons that are inhibitory regulators of movement also lose primary cilia. Without cilia, these neurons are not able to respond to Sonic hedgehog signals that normally induce the expression of Patched RNA, and their numbers decrease. In addition, in mouse, glial cell line–derived neurotrophic factor–related Neurturin RNA is significantly decreased. These experiments highlight the importance of parvalbumin neurons in cilium-dependent, neuroprotective signaling pathways and show that LRRK2 activation correlates with decreased Neurturin production, resulting in less neuroprotection for dopamine neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InterneuronsCiliaParvalbuminsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2NeurturinCorpus StriatumMutationAnimalsMiceHumansParkinson DiseaseMaleSignal Transduction

Substanzen

ParvalbuminsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2NeurturinLRRK2 protein, humanLrrk2 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Bethesda, MD, USA.
  • MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Scotland, UK.
  • Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, USA pfeffer@stanford.edu.

ORCID-Profile: Yu-En Lin, Ebsy Jaimon, Francesca Tonelli, Suzanne R Pfeffer

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Aligning Science Across Parkinson’s
  • National Brain and Tissue Resource for Parkinson’s Disease and Related Disorders
  • Arizona Alzheimer’s Disease Center
  • Arizona Alzheimer’s Research Center
  • Arizona Parkinson’s Disease Consortium

Zitieren

APA

Lin, Y. E., Jaimon, E., Tonelli, F., & Pfeffer, S. R. (2025). Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons. Life Science Alliance, 8(1), e202402922. https://doi.org/10.26508/lsa.202402922

Vancouver

Lin YE, Jaimon E, Tonelli F, Pfeffer SR. Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons. Life Science Alliance. 2025;8(1):e202402922. doi:10.26508/lsa.202402922

BibTeX
@article{Lin2025,
  author = {Lin, Yu-En and Jaimon, Ebsy and Tonelli, Francesca and Pfeffer, Suzanne R},
  title = {Pathogenic LRRK2 mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons},
  journal = {Life Science Alliance},
  year = {2025},
  volume = {8},
  number = {1},
  pages = {e202402922},
  doi = {10.26508/lsa.202402922}
}
Kostenlos starten →